Anika Therapeutics Inc Strategic Asset Allocation Index
Anika Therapeutics Inc strategic asset allocation index. Anika Therapeutics Inc (ANIK) has a Strategic Asset Allocation Index of 17.5% as of June 2023. Strategic assets (PP&E of $47.99 Million plus long-term investments of $-) total $47.99 Million, measured against net assets of $274.01 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Anika Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Anika Therapeutics Inc (2000–2022)
Strategic asset allocation index of Anika Therapeutics Inc from 2000 to 2022. This chart shows how Anika Therapeutics Inc's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 17.5%, representing strategic assets of $47.99 Million against net assets of $274.01 Million USD. Check ANIK goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Anika Therapeutics Inc Strategic Asset Allocation Index by Year (2000–2022)
Anika Therapeutics Inc strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Anika Therapeutics Inc from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Anika Therapeutics Inc (ANIK) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 16.9% | $48.28 Million | $48.28 Million | $- | $285.56 Million | ▲ +0.3 pp |
| 2021 | 16.6% | $47.60 Million | $47.60 Million | $- | $287.08 Million | ▼ -2.0 pp |
| 2020 | 18.6% | $50.61 Million | $50.61 Million | $- | $272.40 Million | ▲ +1.0 pp |
| 2019 | 17.6% | $50.78 Million | $50.78 Million | $- | $288.38 Million | ▼ -2.9 pp |
| 2018 | 20.5% | $54.11 Million | $54.11 Million | $- | $263.61 Million | ▼ -0.8 pp |
| 2017 | 21.3% | $56.18 Million | $56.18 Million | $- | $263.49 Million | ▼ -2.2 pp |
| 2016 | 23.5% | $52.30 Million | $52.30 Million | $- | $222.77 Million | ▲ +4.5 pp |
| 2015 | 19.0% | $40.11 Million | $40.11 Million | $- | $210.85 Million | ▲ +1.2 pp |
| 2014 | 17.8% | $31.67 Million | $31.67 Million | $- | $178.10 Million | ▼ -6.5 pp |
| 2013 | 24.3% | $32.94 Million | $32.94 Million | $- | $135.63 Million | ▼ -8.0 pp |
| 2012 | 32.2% | $35.11 Million | $35.11 Million | $- | $108.93 Million | ▼ -6.2 pp |
| 2011 | 38.5% | $36.47 Million | $36.47 Million | $- | $94.76 Million | ▼ -4.9 pp |
| 2010 | 43.4% | $36.98 Million | $36.98 Million | $- | $85.19 Million | ▼ -0.1 pp |
| 2009 | 43.5% | $35.75 Million | $35.75 Million | $- | $82.14 Million | ▼ -9.6 pp |
| 2008 | 53.1% | $32.25 Million | $32.25 Million | $- | $60.76 Million | ▲ +17.8 pp |
| 2007 | 35.2% | $19.37 Million | $19.37 Million | $- | $54.96 Million | ▲ +28.6 pp |
| 2006 | 6.6% | $3.02 Million | $3.02 Million | $- | $45.49 Million | ▲ +1.1 pp |
| 2005 | 5.5% | $2.10 Million | $2.10 Million | $- | $37.89 Million | ▲ +2.4 pp |
| 2004 | 3.1% | $955.00K | $955.00K | $- | $30.36 Million | ▼ -3.5 pp |
| 2003 | 6.6% | $1.19 Million | $1.19 Million | $- | $17.98 Million | ▼ -4.8 pp |
| 2002 | 11.4% | $1.94 Million | $1.94 Million | $- | $17.06 Million | ▼ -3.3 pp |
| 2001 | 14.7% | $2.95 Million | $2.95 Million | $- | $20.10 Million | ▲ +3.0 pp |
| 2000 | 11.7% | $3.12 Million | $3.12 Million | $- | $26.71 Million | — |